With financial markets remaining turbulent, which sectors and asset classes could present opportunities for an unconstrained multi-asset strategy?

Key Points

  • Rising interest rates, global growth concerns and a less accommodative monetary-policy backdrop highlight the need for careful consideration not just of individual companies but also of thematic trends.
  • We are placing greater emphasis on more defensive businesses, including pharmaceuticals.
  • Other areas of interest from a thematic perspective include renewables and infrastructure, although it is vital to consider valuations carefully.
  • Select commodities also hold appeal as near-term beneficiaries of supply constraints, while copper is an area of secular growth.

Rising interest rates, global growth concerns and a less accommodative monetary-policy backdrop do not optically create a positive cocktail for global equity markets. Indeed, rising bond yields over the last six months have already caused significant collateral damage, with many of the former Covid beneficiaries in the large-cap technology area falling precipitously from their heady heights, feeding through to a wave of cost-cutting. The ripple effects have spread wider, with the spotlight further cast on those companies that are yet to turn a profit, erstwhile dependent on their rising stock prices to fund operations and growth, as well as to attract talent from a tight labor market pool.

While it is not our base case that we will experience a full-scale liquidity event, such developments in the tech sector are concerning. They put the spotlight on the need for a discerning approach to stock picking and the requirement for careful consideration not just of individual companies but also of thematic trends. This marries a full understanding of a business’s fundamentals and stock characteristics with long-term thematic trends such as an ageing population and the influence of big government.

A global thematic approach has been espoused by Newton Investment Management Limited1 since its foundation in 1978, and themes are viewed as providing a more meaningful lens to consider opportunities than traditional sectors. Similarly, a crude geographic classification based on where a company is quoted can be misleading in terms of understanding where the true risk exposure of holdings lies. For instance, while at first glance the European exposure of the equity portion of our Real Return portfolios may appear substantial, the picture looks quite different on a revenue basis, evidencing the limitations of traditional methods of ‘slicing and dicing’ portfolios.

Turning back to themes, while the common thread of these tends to be the ability to capture long-term trends, their relevance over discrete periods is undoubtedly influenced by shorter-term forces and the market cycle itself. For example, we are currently experiencing a period of heightened volatility in markets, exacerbated by geopolitical turmoil, intense inflationary pressures, and the decision of central banks to rein back easy monetary conditions by initiating quantitative tightening (reducing their balance sheets by selling assets).

Equities: A Different Tilt

We believe this ‘regime change’ necessitates a different tilt to equity positioning, with increased emphasis placed on more defensive businesses and a pivot away from long-duration stocks which are vulnerable to rising bond yields. We favor sectors such as health care, including traditional pharmaceutical companies focused on addressing long-term conditions such as cancer, Alzheimer’s and diabetes. There is also recovery potential in areas such as cardiac and eye surgery, given the reduction in the number of elective procedures during the Covid-19 pandemic.

Other areas of interest from a thematic perspective include renewables and infrastructure which, as well as displaying steady, predictable cash flows, have the added role of gaining exposure to long-term projects where cash flows are inflation-linked. We are mindful that there has been a rush to invest in those assets which offer strong ‘green’ credentials, so it is vital to consider valuations carefully.

Considering Commodities

Commodities also hold appeal, but here we believe it is important to be highly selective. While the travails of the major oil companies have been well-publicized, and their transition plans to champion greener energy sources are in the spotlight, we acknowledge that it is likely to be a bumpy ride as scrutiny intensifies around the speed with which they embark on a net-zero path. There is scope for their inclusion in Real Return portfolios as near-term beneficiaries of oil-price buoyancy, aided by the supply constraints created by Russian oil embargoes, although we would want to see meaningful progress made towards energy transition over the longer term, and indeed society is increasingly likely to demand this.

Elsewhere within the commodity spectrum, copper is an area of secular growth, underpinned by near-term supply shortages and the move towards the deployment of renewable generation, the adoption of electric vehicles (the metal is an essential component), and the migration to 5G mobile networks.

In summary, despite the challenges of the febrile backdrop, characterized by short-lived equity market rallies giving way to a resumption of a risk-off tone in markets, we contend that this remains fertile ground to fine-tune portfolios as we seek to ensure they are well-placed for the next phase of markets. Ranking securities by their risk contribution is revealing in this regard, to help ensure that the amount of risk taken is commensurate with our level of conviction.

We maintain a wish list of securities and remain ready to try to take advantage of thematic drivers such as a growth in capital expenditure by companies as the economy emerges from the pandemic, combined with an increase in consumer experiences as activities such as travel resume. While we remain in cautious mode at this juncture, we are deploying our analytical resources to the full to try to take advantage both of valuation opportunities and the varying fortunes of disparate business models.


  1. Newton Investment Management North America (“NIMNA”) was established in 2021. NIMNA is part of the group of affiliated companies that individually or collectively provide investment advisory services under the brand “Newton” or “Newton Investment Management” (“Newton”). Newton currently includes NIMNA and Newton Investment Management Ltd. (“Newton Limited”).

Comments

Your email address will not be published.

Newton does not capture and store any personal information about an individual who accesses this blog, except where he or she volunteers such information, whether via email, an electronic form or other means. Where personal information is supplied, it will be used only in relation to this blog, and will not be collected or stored for any other purpose. Comments submitted via the blog are moderated, and, as a result, there may be a delay before they are posted.

PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS. Any reference to a specific security, country or sector should not be construed as a recommendation to buy or sell this security, country or sector. Please note that strategy holdings and positioning are subject to change without notice. For additional Important Information, click on the link below.

Important information

Issued by Newton Investment Management North America LLC ("NIMNA" or the "Firm"). NIMNA is a registered investment adviser and subsidiary of The Bank of New York Mellon Corporation ("BNY Mellon"). The Firm was established in 2021, comprised of equity and multi-asset teams from an affiliate, Mellon Investments Corporation. The Firm is part of the group of affiliated companies that individually or collectively provide investment advisory services under the brand "Newton" or "Newton Investment Management" ("Newton"). Newton currently includes NIMNA and Newton Investment Management Ltd. ("Newton Limited").

Material in this publication is for general information only. The opinions expressed in this document are those of Newton and should not be construed as investment advice or recommendations for any purchase or sale of any specific security or commodity. Certain information contained herein is based on outside sources believed to be reliable, but its accuracy is not guaranteed. Statements are correct as of the date of the material only. You should consult your advisor to determine whether any particular investment strategy is appropriate.

Personnel of certain of our BNY Mellon affiliates may act as: (i) registered representatives of BNY Mellon Securities Corporation (in its capacity as a registered broker-dealer) to offer securities, (ii) officers of the Bank of New York Mellon (a New York chartered bank) to offer bank-maintained collective investment funds, and (iii) Associated Persons of BNY Mellon Securities Corporation (in its capacity as a registered investment adviser) to offer separately managed accounts managed by BNY Mellon Investment Management firms, including NIMNA and (iv) representatives of Newton Americas, a Division of BNY Mellon Securities Corporation, U.S. Distributor of Newton Investment Management North America.

This material is for institutional investors only. This publication or any portion thereof may not be copied or distributed without prior written approval from the firm.

No investment strategy or risk management technique can guarantee returns or eliminate risk in any market environment and past performance is no indication of future performance.

Any forward-looking statements speak only as of the date they are made, and are subject to numerous assumptions, risks, and uncertainties, which change over time. Actual results could differ materially from those anticipated in forward-looking statements.

Information about the indices shown here is provided to allow for comparison of the performance of the strategy to that of certain well-known and widely recognized indices. There is no representation that such index is an appropriate benchmark for such comparison.

Share